The Link Between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy
Conclusion: As novel cancer therapies are developed, it is paramount to pursue a better understanding of conventional and novel chemotherapeutic agents and their role in kidney disease.
Source: Drug Metabolism Letters - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Drugs & Pharmacology | Nutrition | Urology & Nephrology